Aldosterone, sodium, and hypertension: lessons from torcetrapib?
Funder
John W
JW
Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria 3168, Australia. john.funder@princehenrys.org
D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006973:Hypertension / Q000517:prevention & control*; D011804:Quinolines / Q000627:therapeutic use*; D012680:Sensitivity and Specificity; D012964:Sodium / Q000378:metabolism
D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D011804:Quinolines; D000450:Aldosterone; C483909:torcetrapib; D012964:Sodium